-
1
-
-
0026334918
-
Epidemiology of seasonal and perennial rhinitis: Clinical presentation and medical history
-
Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax. 1991;46:895-901.
-
(1991)
Thorax
, vol.46
, pp. 895-901
-
-
Sibbald, B.1
Rink, E.2
-
2
-
-
0031158329
-
The prevalence and medical and economic impact of allergic rhinitis in the United States
-
Meltzer EO. The prevalence and medical and economic impact of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(6, pt 2):S805-S828.
-
(1997)
J Allergy Clin Immunol
, vol.99
, Issue.6 PART 2
-
-
Meltzer, E.O.1
-
3
-
-
0027973485
-
Epidemiology of physician-diagnosed allergic rhinitis in childhood
-
Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94(6, pt 1):895-901.
-
(1994)
Pediatrics
, vol.94
, Issue.6 PART 1
, pp. 895-901
-
-
Wright, A.L.1
Holberg, C.J.2
Martinez, F.D.3
Halonen, M.4
Morgan, W.5
Taussig, L.M.6
-
4
-
-
0029785409
-
Allergic rhinitis: Clinical practice guideline
-
Fornadley JA, Corey JP, Osguthorpe JD, et al, Committee on Practice Standards, American Academy of Otolaryngic Allergy. Allergic rhinitis: clinical practice guideline. Otolaryngol Head Neck Surg. 1996;115:115-122.
-
(1996)
Otolaryngol Head Neck Surg
, vol.115
, pp. 115-122
-
-
Fornadley, J.A.1
Corey, J.P.2
Osguthorpe, J.D.3
-
5
-
-
0035198737
-
Allergic rhinitis and its impact on asthma
-
Bousquet J, van Cauwenberge P, Khaltaev N, ARIA Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5, suppl):S147-S334.
-
(2001)
J Allergy Clin Immunol
, vol.108
, Issue.5 SUPPL.
-
-
Bousquet, J.1
Van Cauwenberge, P.2
Khaltaev, N.3
-
6
-
-
0028111223
-
Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire
-
Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol. 1994;94(2, pt 1):182-188.
-
(1994)
J Allergy Clin Immunol
, vol.94
, Issue.2 PART 1
, pp. 182-188
-
-
Bousquet, J.1
Bullinger, M.2
Fayol, C.3
Marquis, P.4
Valentin, B.5
Burtin, B.6
-
8
-
-
0031024417
-
A cost of illness study of allergic rhinitis in the United States
-
Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(1, pt 1):22-27.
-
(1997)
J Allergy Clin Immunol
, vol.99
, Issue.1 PART 1
, pp. 22-27
-
-
Malone, D.C.1
Lawson, K.A.2
Smith, D.H.3
Arrighi, H.M.4
Battista, C.5
-
9
-
-
0033963977
-
Consensus statement on the treatment of allergic rhinitis
-
van Cauwenberge P, Bachert C, Passalacqua G, et al, European Academy of Allergology and Clinical Immunology. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000;55:116-134.
-
(2000)
Allergy
, vol.55
, pp. 116-134
-
-
Van Cauwenberge, P.1
Bachert, C.2
Passalacqua, G.3
-
10
-
-
0037728834
-
First do no harm: Managing antihistamine impairment in patients with allergic rhinitis
-
Casale TB, Blaiss MS, Gelfand E, et al, Antihistamine Impairment Roundtable. First do no harm: managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol. 2003;111:S835-S842.
-
(2003)
J Allergy Clin Immunol
, vol.111
-
-
Casale, T.B.1
Blaiss, M.S.2
Gelfand, E.3
-
11
-
-
0035843316
-
Allergy and allergic diseases
-
Kay AB. Allergy and allergic diseases. N Engl J Med. 2001;344:30-37.
-
(2001)
N Engl J Med
, vol.344
, pp. 30-37
-
-
Kay, A.B.1
-
12
-
-
0021831728
-
Inflammatory mediators in late antigen-induced rhinitis
-
Naclerio RM, Proud D, Togias AG, et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985;313:65-70.
-
(1985)
N Engl J Med
, vol.313
, pp. 65-70
-
-
Naclerio, R.M.1
Proud, D.2
Togias, A.G.3
-
14
-
-
0028070733
-
Histamine induces interleukin-8 secretion by endothelial cells
-
Jeannin P, Delneste Y, Gosset P, et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood. 1994;84:2229-2233.
-
(1994)
Blood
, vol.84
, pp. 2229-2233
-
-
Jeannin, P.1
Delneste, Y.2
Gosset, P.3
-
15
-
-
0030218814
-
Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells
-
Miki I, Kusano A, Ohta S, et al. Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol. 1996;171:285-288.
-
(1996)
Cell Immunol
, vol.171
, pp. 285-288
-
-
Miki, I.1
Kusano, A.2
Ohta, S.3
-
16
-
-
0028348206
-
Histamine induces leukocyte rolling in post-capillary venules: A P-selectin-mediated event
-
Kubes P, Kanwar S. Histamine induces leukocyte rolling in post-capillary venules: a P-selectin-mediated event. J Immunol. 1994;152:3570-3577.
-
(1994)
J Immunol
, vol.152
, pp. 3570-3577
-
-
Kubes, P.1
Kanwar, S.2
-
17
-
-
0028215642
-
Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules
-
Asako H, Kurose I, Wolf R, et al. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest. 1994;93:1508-1515.
-
(1994)
J Clin Invest
, vol.93
, pp. 1508-1515
-
-
Asako, H.1
Kurose, I.2
Wolf, R.3
-
18
-
-
0002956172
-
International Consensus Report on the diagnosis and management of rhinitis
-
International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy. 1994;49(19,suppl):1-34
-
(1994)
Allergy
, vol.49
, Issue.19 SUPPL.
, pp. 1-34
-
-
-
19
-
-
0031789449
-
Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
-
Dykewicz MS, Fineman S, Skoner DP, et al, American Academy of Allergy, Asthma, and Immunology. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol. 1998;81(5, pt 2):478-518.
-
(1998)
Ann Allergy Asthma Immunol
, vol.81
, Issue.5 PART 2
, pp. 478-518
-
-
Dykewicz, M.S.1
Fineman, S.2
Skoner, D.P.3
-
21
-
-
0036417223
-
1-antihistamine for the 21st century
-
1-antihistamine for the 21st century. Clin Exp Allergy Rev. 2002;2:18-25.
-
(2002)
Clin Exp Allergy Rev
, vol.2
, pp. 18-25
-
-
Howarth, P.H.1
-
22
-
-
0032711088
-
Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis
-
Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104:927-933.
-
(1999)
J Allergy Clin Immunol
, vol.104
, pp. 927-933
-
-
Howarth, P.H.1
Stern, M.A.2
Roi, L.3
Reynolds, R.4
Bousquet, J.5
-
23
-
-
0029881492
-
Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis
-
Lockey RF, Widlitz MD, Mitchell DQ, et al. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1996;76:448-454.
-
(1996)
Ann Allergy Asthma Immunol
, vol.76
, pp. 448-454
-
-
Lockey, R.F.1
Widlitz, M.D.2
Mitchell, D.Q.3
-
24
-
-
0025892691
-
Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis
-
Falliers CJ, Brandon ML, Buchman E, et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy. 1991;66:257-262.
-
(1991)
Ann Allergy
, vol.66
, pp. 257-262
-
-
Falliers, C.J.1
Brandon, M.L.2
Buchman, E.3
-
25
-
-
34248352628
-
24-Hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]
-
Salmun LM, Lorber R. 24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]. BMC Fam Pract. 2002;3:14.
-
(2002)
BMC Fam Pract
, vol.3
, pp. 14
-
-
Salmun, L.M.1
Lorber, R.2
-
26
-
-
0036408830
-
Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis
-
Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy. 2002;32:1504-1509.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 1504-1509
-
-
Wilson, A.M.1
Haggart, K.2
Sims, E.J.3
Lipworth, B.J.4
-
27
-
-
0037338987
-
Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis
-
Simons FE, Prenner BM, Finn A Jr, Desloratadine Study Group. Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2003;111:617-622.
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 617-622
-
-
Simons, F.E.1
Prenner, B.M.2
Finn Jr., A.3
-
28
-
-
0030782669
-
Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis
-
Bernstein DI, Schoenwetter WF, Nathan RA, Storms W, Ahlbrandt R, Mason J. Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1997;79:443-448.
-
(1997)
Ann Allergy Asthma Immunol
, vol.79
, pp. 443-448
-
-
Bernstein, D.I.1
Schoenwetter, W.F.2
Nathan, R.A.3
Storms, W.4
Ahlbrandt, R.5
Mason, J.6
-
29
-
-
0033127413
-
Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis
-
Casale TB, Andrade C, Qu R. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy Asthma Proc. 1999;20:193-198.
-
(1999)
Allergy Asthma Proc
, vol.20
, pp. 193-198
-
-
Casale, T.B.1
Andrade, C.2
Qu, R.3
-
30
-
-
0034041361
-
Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis
-
van Cauwenberge P, Juniper EF. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy. 2000;30:891-899.
-
(2000)
Clin Exp Allergy
, vol.30
, pp. 891-899
-
-
Van Cauwenberge, P.1
Juniper, E.F.2
-
31
-
-
0023212250
-
Safety and efficacy of loratadine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis
-
Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy. 1987;58:407-411.
-
(1987)
Ann Allergy
, vol.58
, pp. 407-411
-
-
Dockhorn, R.J.1
Bergner, A.2
Connell, J.T.3
-
32
-
-
0023881399
-
Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis
-
Skassa-Brociek W, Bousquet J, Montes F, et al. Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988;81:725-730.
-
(1988)
J Allergy Clin Immunol
, vol.81
, pp. 725-730
-
-
Skassa-Brociek, W.1
Bousquet, J.2
Montes, F.3
-
33
-
-
0031971826
-
Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: Effects after controlled ragweed pollen challenge in an environmental exposure unit
-
Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101:638-645.
-
(1998)
J Allergy Clin Immunol
, vol.101
, pp. 638-645
-
-
Day, J.H.1
Briscoe, M.2
Widlitz, M.D.3
-
34
-
-
1642394844
-
Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: Duration of effect in subjects with seasonal allergic rhinitis
-
Day JH, Briscoe MP, Rafeiro E, Hewlett D Jr, Chapman D, Kramer B. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2004;25:59-68.
-
(2004)
Allergy Asthma Proc
, vol.25
, pp. 59-68
-
-
Day, J.H.1
Briscoe, M.P.2
Rafeiro, E.3
Hewlett Jr., D.4
Chapman, D.5
Kramer, B.6
-
35
-
-
0031449019
-
Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit
-
Day JH, Briscoe MP, Welsh A, et al. Onset of action, efficacy, and safety of a single dose of fexofenadine hydrochloride for ragweed allergy using an environmental exposure unit. Ann Allergy Asthma Immunol. 1997;79:533-540.
-
(1997)
Ann Allergy Asthma Immunol
, vol.79
, pp. 533-540
-
-
Day, J.H.1
Briscoe, M.P.2
Welsh, A.3
-
36
-
-
0031962480
-
Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes
-
Albanesi C, Pasture S, Fanales-Belasio E, Girolomoni G. Cetirizine and hydrocortisone differentially regulate ICAM-1 expression and chemokine release in cultured human keratinocytes. Clin Exp Allergy. 1998;28:101-109.
-
(1998)
Clin Exp Allergy
, vol.28
, pp. 101-109
-
-
Albanesi, C.1
Pasture, S.2
Fanales-Belasio, E.3
Girolomoni, G.4
-
37
-
-
0037661233
-
Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients [published correction appears in Int J Tissue React. 2003;25:79]
-
Pestelli E, Floriani I, Fabbri P, Caproni M. Cetirizine modulates adhesion molecule expression in a double-blind controlled study conducted in psoriatic patients [published correction appears in Int J Tissue React. 2003;25:79]. Int J Tissue React. 2003;25:1-8.
-
(2003)
Int J Tissue React
, vol.25
, pp. 1-8
-
-
Pestelli, E.1
Floriani, I.2
Fabbri, P.3
Caproni, M.4
-
38
-
-
0035319303
-
Desloratadine: A new, nonsedating, oral antihistamine
-
Geha RS, Meltzer EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol. 2001;107:751-762.
-
(2001)
J Allergy Clin Immunol
, vol.107
, pp. 751-762
-
-
Geha, R.S.1
Meltzer, E.O.2
-
39
-
-
0141884366
-
Effects of fexofenadine and other antihistamines on components of the allergic response: Adhesion molecules
-
Ciprandi G, Tosca MA, Cosentino C, Riccio AM, Passalacqua G, Canonica GW. Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J Allergy Clin Immunol. 2003;112(4, suppl):S78-S82.
-
(2003)
J Allergy Clin Immunol
, vol.112
, Issue.4 SUPPL.
-
-
Ciprandi, G.1
Tosca, M.A.2
Cosentino, C.3
Riccio, A.M.4
Passalacqua, G.5
Canonica, G.W.6
-
40
-
-
0032435662
-
Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines
-
Paolieri F, Battifora M, Riccio AM, et al. Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. Ann Allergy Asthma Immunol. 1998;81:601-607.
-
(1998)
Ann Allergy Asthma Immunol
, vol.81
, pp. 601-607
-
-
Paolieri, F.1
Battifora, M.2
Riccio, A.M.3
-
41
-
-
0033746828
-
Sedation and antihistamines: A review of inter-drug differences using proportional impairment ratios
-
Shamsi Z, Hindmarch I. Sedation and antihistamines: a review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2000;15:S3-S30.
-
(2000)
Hum Psychopharmacol
, vol.15
-
-
Shamsi, Z.1
Hindmarch, I.2
-
42
-
-
0032807637
-
Antihistamines: Models to assess sedative properties, assessment of sedation, safety and other side-effects
-
Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy. 1999;29(suppl 3):133-142.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 3
, pp. 133-142
-
-
Hindmarch, I.1
Shamsi, Z.2
-
43
-
-
0030011760
-
Cardiac actions of antihistamines
-
Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol. 1996;36:233-252.
-
(1996)
Annu Rev Pharmacol Toxicol
, vol.36
, pp. 233-252
-
-
Woosley, R.L.1
-
45
-
-
0037477516
-
-
Kenilworth, NJ: Schering Corporation
-
Clarinex [package insert]. Kenilworth, NJ: Schering Corporation; 2002. Available at: www.spfiles.com/piclarinex.pdf. Accessibility verified July 13, 2005.
-
(2002)
Clarinex [Package Insert]
-
-
-
46
-
-
0032803083
-
Cardiovascular safety of fexofenadine HCl
-
Pratt C, Brown AM, Rampe D, et al. Cardiovascular safety of fexofenadine HCl. Clin Exp Allergy. 1999;29(suppl 3):212-216.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 3
, pp. 212-216
-
-
Pratt, C.1
Brown, A.M.2
Rampe, D.3
-
47
-
-
0033562501
-
Cardiovascular safety of fexofenadine HCl
-
Pratt CM, Mason J, Russell T, Reynolds R, Ahlbrandt R. Cardiovascular safety of fexofenadine HCl. Am J Cardiol. 1999;83:1451-1454.
-
(1999)
Am J Cardiol
, vol.83
, pp. 1451-1454
-
-
Pratt, C.M.1
Mason, J.2
Russell, T.3
Reynolds, R.4
Ahlbrandt, R.5
-
48
-
-
0028882348
-
Loratadine administered concomitantly with erythromycin: Pharmacokinetic and electrocardiographic evaluations
-
Brannan MD, Reidenberg P, Radwanski E, et al. Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations. Clin Pharmacol Ther. 1995;58:269-278.
-
(1995)
Clin Pharmacol Ther
, vol.58
, pp. 269-278
-
-
Brannan, M.D.1
Reidenberg, P.2
Radwanski, E.3
-
49
-
-
0032784839
-
Cardiovascular profile of loratadine
-
Hey JA, Affrime M, Cobert B, Kreutner W, Cuss FM. Cardiovascular profile of loratadine. Clin Exp Allergy. 1999;29(suppl 3):197-199.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 3
, pp. 197-199
-
-
Hey, J.A.1
Affrime, M.2
Cobert, B.3
Kreutner, W.4
Cuss, F.M.5
-
50
-
-
0035138854
-
Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast
-
Simons FE, Johnston L, Gu X, Simons KJ. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Ann Allergy Asthma Immunol. 2001;86:44-50.
-
(2001)
Ann Allergy Asthma Immunol
, vol.86
, pp. 44-50
-
-
Simons, F.E.1
Johnston, L.2
Gu, X.3
Simons, K.J.4
-
51
-
-
0035869636
-
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors
-
Triggiani M, Gentile M, Seconde A, et al. Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol. 2001;166:4083-4091.
-
(2001)
J Immunol
, vol.166
, pp. 4083-4091
-
-
Triggiani, M.1
Gentile, M.2
Seconde, A.3
-
52
-
-
0009458726
-
Evaluation of desloratadine for absorption drug-drug interactions with ketoconazole
-
Hwang K, Correll M, Offord SJ. Evaluation of desloratadine for absorption drug-drug interactions with ketoconazole. J Allergy Clin Immunol. 2001;107(2, pt 2):S153.
-
(2001)
J Allergy Clin Immunol
, vol.107
, Issue.2 PART 2
-
-
Hwang, K.1
Correll, M.2
Offord, S.J.3
-
53
-
-
33645595701
-
-
Kansas City, Mo: Avenus Pharmaceuticals, Inc
-
Allegra. Fexofenadine HCl [prescribing information]. Kansas City, Mo: Avenus Pharmaceuticals, Inc; 2003.
-
(2003)
Fexofenadine HCl [Prescribing Information]
-
-
-
55
-
-
0032793959
-
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos. 1999;27:866-871.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
56
-
-
0003056259
-
Reduction of fexofenadine bioavailability by fruit juices
-
Bailey DG, Dresser GK, Munoz C, Freeman DJ, Kim RB. Reduction of fexofenadine bioavailability by fruit juices [abstract]. Clin Pharmacol Ther. 2002;69:P21. Abstract PI-82.
-
(2002)
Clin Pharmacol Ther
, vol.69
-
-
Bailey, D.G.1
Dresser, G.K.2
Munoz, C.3
Freeman, D.J.4
Kim, R.B.5
-
58
-
-
85030743574
-
Determining the membrane permeability of newer antihistamines: Implications for central nervous system function and safety
-
Tejani-Butt S, Yaroslavsky I. Determining the membrane permeability of newer antihistamines: implications for central nervous system function and safety [abstract]. Proc 22nd EAACI. 2003:276. Abstract 959.
-
(2003)
Proc 22nd EAACI
, pp. 276
-
-
Tejani-Butt, S.1
Yaroslavsky, I.2
-
59
-
-
0142059246
-
Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis
-
Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91:354-361.
-
(2003)
Ann Allergy Asthma Immunol
, vol.91
, pp. 354-361
-
-
Hampel, F.1
Ratner, P.2
Mansfield, L.3
Meeves, S.4
Liao, Y.5
Georges, G.6
-
60
-
-
0032803157
-
Assessment of antihistamine efficacy and potency
-
Howarth PH. Assessment of antihistamine efficacy and potency. Clin Exp Allergy. 1999;29(suppl 3):87-97.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 3
, pp. 87-97
-
-
Howarth, P.H.1
-
62
-
-
8644255952
-
Advances in H1-antihistamines
-
Simons FE. Advances in H1-antihistamines. N Engl J Med. 2004;351: 2203-2217.
-
(2004)
N Engl J Med
, vol.351
, pp. 2203-2217
-
-
Simons, F.E.1
-
63
-
-
0032799404
-
A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function
-
Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol. 1999;48:200-206.
-
(1999)
Br J Clin Pharmacol
, vol.48
, pp. 200-206
-
-
Hindmarch, I.1
Shamsi, Z.2
Stanley, N.3
Fairweather, D.B.4
-
64
-
-
0036118760
-
An evaluation of the effects of high-dose fexofenadine on the central nervous system: A double-blind, placebo-controlled study in healthy volunteers
-
Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy. 2002;32:133-139.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 133-139
-
-
Hindmarch, I.1
Shamsi, Z.2
Kimber, S.3
-
65
-
-
0034728807
-
Sedation with "non-sedating" antihistamines: Four prescription-event monitoring studies in general practice
-
Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non- sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ 2000;320:1184-1186.
-
(2000)
BMJ
, vol.320
, pp. 1184-1186
-
-
Mann, R.D.1
Pearce, G.L.2
Dunn, N.3
Shakir, S.4
-
67
-
-
3242751214
-
Central effects of fexofenadine and cetirizine: Measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography
-
Tashiro M, Sakurada Y, Iwabuchi K, et al. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. J Clin Pharmacol. 2004;44:890-900.
-
(2004)
J Clin Pharmacol
, vol.44
, pp. 890-900
-
-
Tashiro, M.1
Sakurada, Y.2
Iwabuchi, K.3
-
68
-
-
0034090862
-
Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: A randomized, placebo-controlled trial in the Iowa driving simulator
-
Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132:354-363.
-
(2000)
Ann Intern Med
, vol.132
, pp. 354-363
-
-
Weiler, J.M.1
Bloomfield, J.R.2
Woodworth, G.G.3
-
69
-
-
4043089083
-
Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements
-
Vuurman EF, Rikken GH, Muntjewerff ND, de Haileux F, Ramaekers JG. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. Eur J Clin Pharmacol. 2004;60:307-313.
-
(2004)
Eur J Clin Pharmacol
, vol.60
, pp. 307-313
-
-
Vuurman, E.F.1
Rikken, G.H.2
Muntjewerff, N.D.3
De Haileux, F.4
Ramaekers, J.G.5
-
70
-
-
0042877021
-
Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: A randomized, double-blind, placebo-controlled trial
-
Verster JC, de Weert AM, Bijtjes SI, et al. Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2003;169:84-90.
-
(2003)
Psychopharmacology (Berl)
, vol.169
, pp. 84-90
-
-
Verster, J.C.1
De Weert, A.M.2
Bijtjes, S.I.3
-
71
-
-
0026540567
-
Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving
-
Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363-369.
-
(1992)
Eur J Clin Pharmacol
, vol.42
, pp. 363-369
-
-
Ramaekers, J.G.1
Uiterwijk, M.M.2
O'Hanlon, J.F.3
-
72
-
-
0034142033
-
Cardiotoxic potential and CNS effects of first-generation antihistamines
-
Taglialatela M, Timmerman H, Annunziato L. Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends Pharmacol Sci. 2000; 21:52-56.
-
(2000)
Trends Pharmacol Sci
, vol.21
, pp. 52-56
-
-
Taglialatela, M.1
Timmerman, H.2
Annunziato, L.3
-
73
-
-
0032815515
-
A review of the cardiac systemic side-effects of antihistamines: Ebastine
-
Moss AJ, Chaikin P, Garcia JD, Gillen M, Roberts DJ, Morganroth J. A review of the cardiac systemic side-effects of antihistamines: ebastine. Clin Exp Allergy. 1999;29(suppl 3):200-205.
-
(1999)
Clin Exp Allergy
, vol.29
, Issue.SUPPL. 3
, pp. 200-205
-
-
Moss, A.J.1
Chaikin, P.2
Garcia, J.D.3
Gillen, M.4
Roberts, D.J.5
Morganroth, J.6
-
74
-
-
0036279872
-
Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit
-
Horak F, Stubner UP, Zieglmayer R, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol. 2002;109:956-961.
-
(2002)
J Allergy Clin Immunol
, vol.109
, pp. 956-961
-
-
Horak, F.1
Stubner, U.P.2
Zieglmayer, R.3
Harris, A.G.4
-
75
-
-
0034067927
-
Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis
-
Nunes C, Ladeira S. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis. J Investig Allergol Clin Immunol. 2000;10:20-23.
-
(2000)
J Investig Allergol Clin Immunol
, vol.10
, pp. 20-23
-
-
Nunes, C.1
Ladeira, S.2
-
76
-
-
0036408830
-
Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis
-
Wilson AM, Haggart K, Sims EJ, Lipworth BJ. Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis. Clin Exp Allergy. 2002;32:1504-1509.
-
(2002)
Clin Exp Allergy
, vol.32
, pp. 1504-1509
-
-
Wilson, A.M.1
Haggart, K.2
Sims, E.J.3
Lipworth, B.J.4
-
77
-
-
0032845559
-
Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire
-
Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J Allergy Clin Immunol. 1999;104(2, pt 1):364-369.
-
(1999)
J Allergy Clin Immunol
, vol.104
, Issue.2 PART 1
, pp. 364-369
-
-
Juniper, E.F.1
Thompson, A.K.2
Ferrie, P.J.3
Roberts, J.N.4
-
78
-
-
0029791103
-
Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire
-
Bousquet J, Duchateau J, Pignat JC, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. J Allergy Clin Immunol. 1996;98:309-316.
-
(1996)
J Allergy Clin Immunol
, vol.98
, pp. 309-316
-
-
Bousquet, J.1
Duchateau, J.2
Pignat, J.C.3
-
79
-
-
0032946674
-
Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis
-
Tanner LA, Reilly M, Meltzer EO, Bradford JE, Mason J. Effect of fexofenadine HCl on quality of life and work, classroom, and daily activity impairment in patients with seasonal allergic rhinitis. Am J Manag Care. 1999; 5:S235-S247.
-
(1999)
Am J Manag Care
, vol.5
-
-
Tanner, L.A.1
Reilly, M.2
Meltzer, E.O.3
Bradford, J.E.4
Mason, J.5
-
80
-
-
15844380989
-
Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season
-
Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol. 2005;136:148-154.
-
(2005)
Int Arch Allergy Immunol
, vol.136
, pp. 148-154
-
-
Okubo, K.1
Gotoh, M.2
Shimada, K.3
Ritsu, M.4
Okuda, M.5
Crawford, B.6
-
81
-
-
0032697271
-
Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis
-
Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1999;83:311-317.
-
(1999)
Ann Allergy Asthma Immunol
, vol.83
, pp. 311-317
-
-
Meltzer, E.O.1
Casale, T.B.2
Nathan, R.A.3
Thompson, A.K.4
-
82
-
-
0037337119
-
The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: A randomized double-blind, placebo-controlled trial
-
Noonan MJ, Raphael GD, Nayak A, et al. The health-related quality of life effects of once-daily cetirizine HCl in patients with seasonal allergic rhinitis: a randomized double-blind, placebo-controlled trial. Clin Exp Allergy. 2003;33:351-358.
-
(2003)
Clin Exp Allergy
, vol.33
, pp. 351-358
-
-
Noonan, M.J.1
Raphael, G.D.2
Nayak, A.3
-
83
-
-
0036878197
-
Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: Impact on symptoms, quality of life, productivity, and activity impairment
-
Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D, Kramer B. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc. 2002;23:391-398.
-
(2002)
Allergy Asthma Proc
, vol.23
, pp. 391-398
-
-
Murray, J.J.1
Nathan, R.A.2
Bronsky, E.A.3
Olufade, A.O.4
Chapman, D.5
Kramer, B.6
-
84
-
-
0034082414
-
Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: Efficacy and quality of life
-
Condemi J, Schulz R, Lim J. Triamcinolone acetonide aqueous nasal spray versus loratadine in seasonal allergic rhinitis: efficacy and quality of life. Ann Allergy Asthma Immunol. 2000;84:533-538.
-
(2000)
Ann Allergy Asthma Immunol
, vol.84
, pp. 533-538
-
-
Condemi, J.1
Schulz, R.2
Lim, J.3
-
85
-
-
4944246449
-
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis
-
Bachert C, Bousquet J, Canonica GW, et al, XPERT Study Group. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004;114: 838-844.
-
(2004)
J Allergy Clin Immunol
, vol.114
, pp. 838-844
-
-
Bachert, C.1
Bousquet, J.2
Canonica, G.W.3
-
86
-
-
0141465572
-
Health-related quality of life outcomes of desloratadine in patients with moderate-to-severe SAR
-
Schmier J, Leidy N, Prasad M. Health-related quality of life outcomes of desloratadine in patients with moderate-to-severe SAR [abstract]. Ann Allergy Asthma Immunol. 2001;86:111. Abstract P69.
-
(2001)
Ann Allergy Asthma Immunol
, vol.86
, pp. 111
-
-
Schmier, J.1
Leidy, N.2
Prasad, M.3
-
87
-
-
0001518177
-
Quality of life in patients with seasonal allergic rhinitis is improved by desloratadine
-
Coren J, Salmun M. Quality of life in patients with seasonal allergic rhinitis is improved by desloratadine. Allergy. 2000;55(suppl 63):191.
-
(2000)
Allergy
, vol.55
, Issue.SUPPL. 63
, pp. 191
-
-
Coren, J.1
Salmun, M.2
-
88
-
-
85030748428
-
-
First Word, April 21
-
Hoffmann C. Seasonal allergy treatment affected by OTC Claritin. First Word, April 21, 2003. Available at: www.firstwordplus.com/Fws.do?articleid= 0053C577AEE5A70285256D0F00740323. Accessibility verified July 13, 2005.
-
(2003)
Seasonal Allergy Treatment Affected by OTC Claritin
-
-
Hoffmann, C.1
|